SYPRIS SOLUTIONS INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data SYPRIS SOLUTIONS INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	91.8	82.3	88	87.9	82.3	97.4	110	136	140	120
Cost of revenue	91	79	80.4	78	70.3	82.9	95.3	119	120	110
Gross profit	0.75	3.33	7.57	9.88	12.1	14.5	14.9	17.2	19.9	9.4
Research and development	0.33	0.04	0
Selling, general and administrative	22	13.1	10.5	13.7	12	12.6	14.5	16.3	17	16
Operating income	-22.8	-12.1	-4.3	-4.31	0.09	1.91	0.36	0.97	2.93	-6.61
Interest expense	4.88	0.81	0.85	0.9	0.84	0.87	1.11	0.78	1.68	1.63
Other non-operating income	35.5	1.52	1.44	1.26	-0.54	-0.65	-0.8	-1.13	-1.22	1.96
Pre-tax income	6.34	-11.4	-3.71	-3.95	-1.29	4	-1.55	-0.93	0.03	-6.28
Income tax	0.3	-0.62	-0.21	-0	-2.96	1.07	0.95	0.66	1.71	0.06
Income from continuing operations	6.04
Net income	6.04	-10.8	-3.51	-3.95	1.67	2.92	-2.49	-1.6	-1.68	-6.34
EBITDA	-16.5	-8.26	-1.65	-1.64	2.59	4.56	3.45	4.23	6.11	-3.76
EPS, basic	0.30	-0.53	-0.17	-0.19	0.08	0.14	-0.11	-0.07	-0.08	-0.28
EPS, diluted	0.30	-0.53	-0.17	-0.19	0.08	0.13	-0.11	-0.07	-0.08	-0.28
Shares, basic (weighted)	19.9	0.02	20.5	20.9	21.1	21.6	21.7	21.9	22	22.3
Shares, diluted (weighted)	19.9	0.02	20.5	20.9	21.1	23	21.7	21.9	22	22.3
Dividend per share	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	16.8	8.14	10.7	5.1
Receivables	8.01	9.32	9.88	7.44	7.23	8.47	8.06	8.93	10.6	9.85
Inventory	14.6	17.6	18.6	20.8	16.2	30.1	42.1	77.3	66.7	52.5
Other current assets	2.73	2	4.76	4.28	4.36	5.87	8.13	9.74	11.1	10.8
Total current assets	42.9	40	45.4	39.8	39.4	56.1	80	104	98	79.9
Property, plant and equipment	17.9	15.6	14.7	11.7	10.2	14.1	15.5	17.1	13.3	16
Lease right-of-use assets			0	7.01	6.1	5.14	4.25	3.31	3.75	7.33
Other non-current assets	1.79	1.58	1.52	1.53	5.01	4.17	4.38	5.03	4.31	4.59
Total assets	62.6	57.2	61.6	60.1	60.7	79.5	104	129	119	108
Accounts payable	6.69	10.5	13.4	9.35	6.73	12	17.6	26.7	18.4	10.3
Accrued liabilities	10.8	10.3	15	12.5	12	19.6	33.3	56.2	57.6	49.4
Deferred revenue			8.37	5.77	6.82	15	27.9	49.7	50.4	42.3
Short-term debt	0	0.83	0.59	0.68	1.58	1.32	4	2.45	2.49	1.65
Total current liabilities	17.7	21.6	29	23.4	21.2	34	56.1	86.5	79.5	62.4
Long-term debt	2.95	3.4	2.8	0	2.37	0	3.99	6.48	8.99	12
Lease liabilities			0	6.91	5.94	4.88	3.71	2.64	3.25	6.67
Other non-current liabilities	9.49	8.77	8.5	7.54	7.97	10.5	17.5	8.08	6.51	4.12
Total liabilities	36.5	40.2	46.7	46.6	45.9	60.2	84.6	107	99.8	90
Total debt	0	4.23	3.4	0.68	1.58	1.32	4	2.45	2.49	1.65
Paid-in capital	153	154	154	155	155	155	156	156	157	158
Retained earnings	-0.1	-112	-115	-117	-116	-113	-115	-117	-119	-125
Treasury stock	0	0	0	0	0	0	0	0	0	0
Other comprehensive income	-26.6	-25.6	-24.8	-24.1	-24.7	-23	-20.8	-17.1	-19	-15.5
Shareholders' equity	26.1	16.9	14.8	13.4	14.8	19.3	19.6	22.5	19.6	17.8
Total equity	26.1	16.9	14.8	13.4	14.8	19.3	19.6	22.5	19.6	17.8
Total liabilities and equity	62.6	57.2	61.6	60.1	60.7	79.5	104	129	119	108
Shares outstanding	21.3	21.4	21.4	21.3	21.3

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	6.04	-10.8	-3.51	-3.95	1.67	2.92	-2.49	-1.6	-1.68	-6.34
Depreciation and amortization	6.29	3.88	2.65	2.67	2.5	2.65	3.09	3.26	3.18	2.84
Stock-based compensation	1.37	0.73	0.64	0.47	0.43	0.49	0.68	0.81	0.87	1.12
Deferred income tax	0	-0.67	-0.51	-0.26	-3.07	1.02	0.33	0.05	0.23	0.11
Change in receivables	4.07	-1.42	-0.61	2.43	0.21	-1.27	0.35	-1.1	-1.83	0.69
Change in inventory	-1.81	-3.2	-2.86	-2.62	4.23	-14	-11.8	-34.7	9.13	13.3
Change in payables	-4.61	3.49	2.95	-4.1	-2.59	5.27	5.56	8.98	-8.16	-8.24
Cash from operations	-19.3	-9.46	1.89	-5.85	3.65	4.24	13.8	-11.1	2	-5.73
Capital expenditures	-1.76	-1.64	-2.05	-0.86	-1.54	-2.82	-3.04	-2.14	-1.08	-0.76
Cash from investing	48.3	1.16	1.6	1	0.43	-2.81	-3.03	-2.14	-1.06	2.17
Debt issued	0
Debt repaid	-11.7	0
Dividends paid	0
Cash from financing	-15.1	-0.33	-0.94	-0.79	2.74	-1.28	-1.38	-0.61	0.82	0.84
Net change in cash	13.9	-8.63	2.56	-5.61	6.51	0.01	10	-13.8	1.79	-2.91
Free cash flow	-21.1	-11.1	-0.16	-6.71	2.11	1.41	10.8	-13.2	0.92	-6.49
Interest paid	3.58	0.53	0.53	0.53	0.37	0.7	0.53	0.48	0.28

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 5, 2026; growth uses fiscal years. Valuation uses the share price of $1.74 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	5.4%	Gross profit / revenue.
Operating margin	-9.6%	Operating income / revenue.
EBITDA margin	-7.1%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-9.6%	Pre-tax income / revenue.
Net margin	-9.2%	Net income / revenue.
FCF margin	-2.6%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	-1.5%	Cash from operations / revenue.
Return on equity (ROE)	-90.6%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-10.1%	Net income / average total assets.
Return on invested capital (ROIC)	-57.0%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	15.1%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.1%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.0%	Capital expenditures / revenue.
D&A / revenue	2.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-14.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	2.9%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	7.8%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-52.8%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-14.2%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-4.9%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-325.7%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	-161.6%	EBITDA vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	-386.0%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y	-804.3%	Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	-9.1%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-3.1%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	3.8%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-9.7%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	1.2%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	12.2%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	1.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.8%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	1.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.26x	Current assets / current liabilities.
Debt / equity	0.31x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	3.5%	Total debt / total assets.
Liabilities / assets	88.9%	Total liabilities / total assets.
Interest coverage	-5.60x	Operating income / interest expense.
Working capital	$16.1M	Current assets - current liabilities.
Tangible book value	$11.7M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.09x	Revenue / average total assets.
Fixed asset turnover	7.43x	Revenue / average property, plant and equipment.
Inventory turnover	2.15x	Cost of revenue / average inventory.
Days inventory	169 days	365 x average inventory / cost of revenue.
Receivables turnover	11.0x	Revenue / average receivables.
Days sales outstanding	33 days	365 x average receivables / revenue.
Days payables	42 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	161 days	Days inventory + days sales outstanding - days payables.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.47	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$5.13	Revenue / diluted weighted shares.
FCF per share	-$0.13	Free cash flow / diluted weighted shares.
Operating cash flow per share	-$0.08	Cash from operations / diluted weighted shares.
Book value per share	$0.52	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$0.52	Tangible book value / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$40.0M	Share price x shares outstanding.
Enterprise value	$43.7M	Market cap + total debt - cash - short-term investments.
P/S	0.35x	Market cap / revenue.
P/B	3.42x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	3.42x	Market cap / tangible book value, when positive.
EV/Sales	0.38x	Enterprise value / revenue.
FCF yield	-7.3%	Free cash flow / market cap.
Earnings yield	-26.5%	Net income / market cap (the inverse of P/E).

What was SYPRIS SOLUTIONS INC's revenue in fiscal 2025?

SYPRIS SOLUTIONS INC reported revenue of $119.9M for fiscal 2025, 14.5% lower than the year before.

Was SYPRIS SOLUTIONS INC profitable in fiscal 2025?

No. It reported a net loss of $6.3M.

How much free cash flow did SYPRIS SOLUTIONS INC generate in fiscal 2025?

Cash from operations of $5.7M minus capital expenditures of $756.0K left free cash flow of -$6.5M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to SYPRIS SOLUTIONS INC